Literature DB >> 25496253

Targeting an acid labile aspartyl-prolyl amide bond as a viable alternative to trypsin digestion to generate a surrogate peptide for LC-MS/MS analysis.

Eliza N Fung1, Frank Zambito, Jonathan Haulenbeek, Steven P Piccoli, Yan Zhang, Binodh DeSilva, Mark Arnold, Alexander Kozhich.   

Abstract

BACKGROUND: FGF21-AdPKE is a fusion protein and functionally inactivated in vivo by cleavage around the C-terminus. It is important to quantify the intact active protein in serum. RESULTS & DISCUSSION: Taking advantage of a uniquely acid-labile aspartyl-prolyl amide bond, we developed an acid hydrolysis procedure based on heating FGF21-AdPKE in dilute formic acid to generate a surrogate peptide encompassing the last 17 amino acids at the C-terminus. The monkey serum samples were extracted with an immunocapture procedure with an antibody specific for AdPKE. The calibration range was 200-50000 ng/ml. The assay accuracy and precision were between 92.8-99.8% and 3.9-14.5%, respectively. The method was applied to analyze incurred serum samples from a cynomolgus monkey toxicokinetic study involving administration of FGF21-AdPKE.
CONCLUSION: A method of combining immunocapture and acid hydrolysis to quantify a therapeutic protein in biological fluids was developed.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25496253     DOI: 10.4155/bio.14.182

Source DB:  PubMed          Journal:  Bioanalysis        ISSN: 1757-6180            Impact factor:   2.681


  2 in total

1.  A Commensal Dipeptidyl Aminopeptidase with Specificity for N-Terminal Glycine Degrades Human-Produced Antimicrobial Peptides in Vitro.

Authors:  Janice H Xu; Zhenze Jiang; Angelo Solania; Sandip Chatterjee; Brian Suzuki; Christopher B Lietz; Vivian Y H Hook; Anthony J O'Donoghue; Dennis W Wolan
Journal:  ACS Chem Biol       Date:  2018-08-23       Impact factor: 5.100

2.  Opportunities and challenges for hybrid immunoaffinity LC-MS approach for quantitative analysis of protein biomarkers.

Authors:  Yue Zhao; Huidong Gu; Jianing Zeng
Journal:  Future Sci OA       Date:  2018-02-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.